Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Neoplasms 4 Esophageal Squamous Cell Carcinoma 3 Uterine Cervical Neoplasms 2 Lymphatic Metastasis 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Neoplasm Metastasis 1 Melanoma 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Ductal, Breast 1

Interventions

Cisplatin 47 Radiotherapy 37 Fluorouracil 23 Cetuximab 17 pembrolizumab 11 Carboplatin 11 Paclitaxel 8 Docetaxel 8 Radiotherapy, Intensity-Modulated 6 Chemotherapy, Adjuvant 6 Surgical Procedures, Operative 5 Standard of Care 5 nimotuzumab 4 Methotrexate 4 Gabapentin 4 Drug Therapy 4 Afatinib 4 Radiotherapy, Conformal 3 Radiation 3 Porfiromycin 3 Nivolumab 3 Neoadjuvant Therapy 3 Fibroblast Growth Factor 7 3 Bleomycin 3 zalutumumab 2 sargramostim 2 epacadostat 2 Tranexamic Acid 2 Tirapazamine 2 Pilocarpine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Head and Neck Neoplasms × TP protocol × Clear all

NCT01126216 2021-05-04

Paccis-RCT

University of Erlangen-Nürnberg Medical School

Phase 3 Terminated

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡